Linda T. Vahdat, MD provides a comprehensive update on recent advances and emerging data in the treatment of metastatic breast cancer with focus on novel anti-microtubule agents and new strategies for overcoming resistance.

Program Includes: Interactive slide presentations and downloadable PowerPoint slides

Available until January 2009, this activity offers:
Physicians: 1 AMA PRA Category 1 Credit^™
Nurses: 1 contact hour
Pharmacists: 1 contact hour (0.1 CEU)

This CME series is jointly sponsored by Medical Education Resources (MER), a non-profit medical education company in Littleton, Colorado, and Oncology Associates, LLC, an independent medical education company providing up-to-date medical information to healthcare professionals who care for patients with cancer.

This series is made possible by educational grants from Bristol-Myers Squibb Company.